Trials / Terminated
TerminatedNCT03052972
Flortaucipir 18F PET Imaging in BIOCARD Study
Flortaucipir (18F) PET Imaging in the BIOCARD Study
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | 370 megabecquerel (MBq)(10 millicurie \[mCi\]) single dose |
| PROCEDURE | Brain PET scan | positron emission tomography (PET) scan of the brain |
Timeline
- Start date
- 2017-03-23
- Primary completion
- 2018-08-14
- Completion
- 2018-08-17
- First posted
- 2017-02-14
- Last updated
- 2020-09-25
- Results posted
- 2020-08-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03052972. Inclusion in this directory is not an endorsement.